| Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: current state of the art C Solinas, L Carbognin, P De Silva, C Criscitiello, M Lambertini The Breast 35, 142-150, 2017 | 123 | 2017 |
| Immune checkpoint molecules on tumor-infiltrating lymphocytes and their association with tertiary lymphoid structures in human breast cancer C Solinas, S Garaud, P De Silva, A Boisson, G Van den Eynden, ... Frontiers in immunology 8, 1412, 2017 | 110 | 2017 |
| Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity G Noël, ML Fontsa, S Garaud, P De Silva, A De Wind, ... The Journal of clinical investigation 131 (19), 2021 | 105 | 2021 |
| LAG3: the biological processes that motivate targeting this immune checkpoint molecule in human cancer C Solinas, E Migliori, P De Silva, K Willard-Gallo Cancers 11 (8), 1213, 2019 | 90 | 2019 |
| Homologous recombination repair deficiency and the immune response in breast cancer: a literature review B Pellegrino, A Musolino, A Llop-Guevara, V Serra, P De Silva, Z Hlavata, ... Translational oncology 13 (2), 410-422, 2020 | 70 | 2020 |
| Immunotherapy associated pulmonary toxicity: biology behind clinical and radiological features M Porcu, P De Silva, C Solinas, A Battaglia, M Schena, M Scartozzi, ... Cancers 11 (3), 305, 2019 | 70 | 2019 |
| A simple and rapid protocol to non-enzymatically dissociate fresh human tissues for the analysis of infiltrating lymphocytes S Garaud, C Gu-Trantien, JN Lodewyckx, A Boisson, P De Silva, ... JoVE (Journal of Visualized Experiments), e52392, 2014 | 67 | 2014 |
| Significance of TIM3 expression in cancer: From biology to the clinic C Solinas, P De Silva, D Bron, K Willard-Gallo, D Sangiolo Seminars in oncology 46 (4-5), 372-379, 2019 | 65 | 2019 |
| Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy C Solinas, M Porcu, Z Hlavata, P De Silva, M Puzzoni, K Willard-Gallo, ... Critical reviews in oncology/hematology 120, 13-21, 2017 | 63 | 2017 |
| Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization—a Thomas Dougherty Award for Excellence in PDT paper P De Silva, MA Saad, HC Thomsen, S Bano, S Ashraf, T Hasan Journal of Porphyrins and Phthalocyanines 24 (11n12), 1320-1360, 2020 | 59 | 2020 |
| Cancer immunotherapy-associated hypophysitis C Solinas, M Porcu, P De Silva, M Musi, S Aspeslagh, M Scartozzi, ... Seminars in oncology 45 (3), 181-186, 2018 | 53 | 2018 |
| Luminal breast cancer: risk of recurrence and tumor-associated immune suppression B Pellegrino, Z Hlavata, C Migali, P De Silva, M Aiello, K Willard-Gallo, ... Molecular Diagnosis & Therapy 25 (4), 409-424, 2021 | 45 | 2021 |
| Vitamin D receptor activation and photodynamic priming enables durable low-dose chemotherapy S Anbil, M Pigula, HC Huang, S Mallidi, M Broekgaarden, Y Baglo, ... Molecular cancer therapeutics 19 (6), 1308-1319, 2020 | 38 | 2020 |
| BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer C Solinas, D Marcoux, S Garaud, JR Vitória, G Van den Eynden, ... Cancer Letters 450, 88-97, 2019 | 38 | 2019 |
| FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer P De Silva, S Garaud, C Solinas, A de Wind, G Van den Eyden, V Jose, ... EBioMedicine 39, 226-238, 2019 | 36 | 2019 |
| FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders S Garaud, F Roufosse, P De Silva, C Gu‐Trantien, JN Lodewyckx, ... European journal of immunology 47 (1), 168-179, 2017 | 34 | 2017 |
| Targeting CTLA‐4 in cancer: Is it the ideal companion for PD‐1 blockade immunotherapy combinations? P De Silva, M Aiello, C Gu‐Trantien, E Migliori, K Willard‐Gallo, C Solinas International journal of cancer 149 (1), 31-41, 2021 | 32 | 2021 |
| The abscopal effect in the era of cancer immunotherapy: a spontaneous synergism boosting anti-tumor immunity? Z Hlavata, C Solinas, P De Silva, M Porcu, L Saba, K Willard-Gallo, ... Targeted Oncology 13, 113-123, 2018 | 29 | 2018 |
| Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2 BA Trombetta, SE Kandigian, RR Kitchen, K Grauwet, PK Webb, GA Miller, ... BMC infectious diseases 21 (1), 580, 2021 | 25 | 2021 |
| Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor‐associated myocarditis R Cau, C Solinas, P De Silva, M Lambertini, E Agostinetto, M Scartozzi, ... International Journal of Cancer 151 (11), 1860-1873, 2022 | 22 | 2022 |
